Navigation Links
Dendreon to Host Conference Call to Provide Updates on U.S. Commercialization Progress, European Strategy for PROVENGE, and Pipeline Progress
Date:1/6/2011

SEATTLE, Jan. 6, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) management will host a conference call on Friday, January 7, 2011 at 9:00 a.m. ET to provide updates on U.S. commercialization progress, European strategy for PROVENGE, and pipeline progress.Date:

Friday, January 7, 2011Time:

9:00 a.m. ET / 6:00 a.m. PTDial-in:

1-877-548-9590 (domestic) or +1-720-545-0037 (international);conference pass code 35063654Webcast:

www.dendreon.com (homepage and investor relations section)A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-800-642-1687 or +1-706-645-9291 for international callers; the conference ID number is 35063654. The replay will be available from 12:00 p.m. ET on Friday, January 7 until 11:59 p.m. ET on Monday, January 10.  In addition the webcast will be archived for on-demand listening for 30 days at www.dendreon.com.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon's first product, PROVENGE® (sipuleucel-T), was approved by the FDA in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. The Company is headquartered in Seattle, Washington and is traded on the NASDAQ Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces MEDCAC Panel Reviewed PROVENGE Evidence
2. Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility
3. Dendreon to Host Conference Call on November 3rd to Announce Third Quarter Financial Results
4. Dendreon Announces Change in Board of Directors
5. Dendreon Announces Election of Dr. David C. Stump to Board of Directors
6. Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting
7. Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering
8. Dendreon Announces Pricing of Common Stock Offering
9. Dendreon Appoints Hans Bishop as Chief Operating Officer
10. Dendreon Announces Proposed Public Offering of Common Stock
11. Dendreon Receives FDA Acknowledgement of Complete Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... ... preclinical PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) in existing third-party ... and testing novel treatments in small animal subjects. Simultaneous PET/MRI imaging offers a ...
(Date:4/27/2016)... 2016 ReportsnReports.com adds 2016 ... focus on US, EU, China ... the healthcare business intelligence collection of its growing ... report on the Flow Cytometry market spread across ... 282 tables and figures is now available at ...
(Date:4/26/2016)... Baden-Württemberg (PRWEB) , ... April 26, 2016 , ... ... of laser lithography systems, announces the latest technology innovation for its Volume Pattern ... fulfill tomorrow’s demand for production of advanced photomasks as well as a solution ...
(Date:4/26/2016)... ... April 26, 2016 , ... Seattle based ... operating grant from 1Plus12 Corporation. The grant will be used to further the ... on the organization's website http://www.ivsci.org , In accounting the grant to ...
Breaking Biology Technology:
(Date:3/10/2016)... Pa. , March 10, 2016   Unisys Corporation ... Customs and Border Protection (CBP) is testing its biometric ... San Diego to help identify certain non-U.S. ... . The test, designed to help determine the efficiency ... environment, began in February and will run until May 2016. ...
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
(Date:3/2/2016)... , March 2, 2016 ... the addition of the  "Global Biometrics Market ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , Global ... grow at a CAGR of around 27% ... ) has announced the addition of the  ...
Breaking Biology News(10 mins):